Kirk Warshaw
elected Kirk Warshaw to serve as a member of the Board
Highest-materiality recent filing
Sono-Tek Q3 FY2026 net income +24% YoY to $340K; record backlog $12.3M
Q3 net sales $5.0M, 7th consecutive quarter >$5M; gross margin expanded to 50% from 45%.
Sono-Tek Q2 net income up 24% YoY to $424K; first-half revenue record $10.30M
Q2 net sales flat at $5.16M; net income up 24% YoY to $424K ($0.03 EPS).
Sono-Tek Q2 net income up 24% to $424k; medical sales surge 150% YoY; backlog up 50% sequentially
Q2 net sales $5.163M (flat YoY); net income $424k (+24%); EPS $0.03 vs $0.02.
Sono-Tek wins $2.8M order for medical device coating systems from major US manufacturer
Purchase order valued at over $2.8M from major U.S. medical device maker; deliveries start early 2026, complete by H1 2026.
Sono-Tek receives $5M+ order for MediCoat medical device coating systems
Purchase order valued at over $5 million for multiple MediCoat systems.
Gross margin improved to 52% from 49%; operating income rose 103% to $483K due to higher gross profit and lower expenses.
Record annual revenue $20.5M (+4% YoY); net income $1.3M vs $1.4M prior year (down ~9%).
elected Kirk Warshaw to serve as a member of the Board
Philip Strasburg, a current member of the Board who serves on the Board’s Audit and Compensation Committees, has indicated that he does not intend to stand for reelection to the Board and will resign effective upon the completion of the Company’s next annual meeting of shareholders to be held in August 2025.
Max materiality 0.75 · Median 0.70 · Most common event earnings